Omega6 Conjugated-Linoleic Acid (CLA)
CLA may have anti-carcinogenic effects. Research suggests that it is associated with a decreased risk of breast cancer and the reduction of chemically-induced cancers in animals. In a study conducted by Chin et al, rats fed diets containing 0.5% or 1.5% CLA had a total reduction of the number of breast-cancer tumours by 32% and 56%, respectively.
CLA decreases LDL cholesterol by influencing body composition and reducing fat while maintaining and increasing lean body mass. In a study by Gaullier et. al., human participants showed a 9% reduction in body fat and a 2% increase in lean body mass, with no change in diet or exercise. CLA reduces the rate at which fat cells grow and encourages muscle development by ensuring that glucose is quickly directed straight to the muscle cells, before it can nourish unwanted fat cells.
CLA promotes cardiovascular health by preventing the build-up of fatty deposits in the arteries and around the heart. Studies have shown that diets rich in CLA reduce the likelihood of symptoms of atherosclerosis developing.
Enhanced immune function may result from a diet rich in CLA. In one study published in Poultry Science, chicks fed a diet containing 0.5% CLA were found to have stronger immune systems than those that were not. Results showed that they had improvedseek-and-destroy capabilities for targeting invading bacteria.